Chantix Tablet, Film Coated
Product Images NDC 0069-0469

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Chantix (NDC 0069-0469). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chantix 01)

Chemical structure diagram of varenicline tartrate, the active ingredient in CHANTIX tablets. The structure shows molecular components with labeled functional groups, characteristic of varenicline's chemical makeup.*

FDA Label Image

Figure 1 (Chantix 02)

A vertical bar chart comparing percentage outcomes across multiple studies for CHANTIX (varenicline tartrate) at different dosages and other treatments versus placebo. The x-axis labels represent different studies and treatments, while the y-axis shows percentage values ranging from 0% to 60%. Each category has bars with error bars indicating variability.*

FDA Label Image

Figure 2 (Chantix 03)

A bar chart comparing the percentage outcomes for CHANTIX 0.5 mg BID, CHANTIX 1.0 mg BID, CHANTIX Flexible, and placebo across five studies, including Study 2, Study 3, Study 4, and Study 5. Study 4 and Study 5 also include comparisons with Bupropion SR 150 mg BID. The chart shows error bars for each treatment group indicating variability around the mean values.*

FDA Label Image

Figure 3 (Chantix 04)

A line graph comparing the percentage of continuous abstinent patients over time during nontreatment follow-up weeks for CHANTIX 1 mg BID versus placebo. The x-axis represents weeks of follow-up, and the y-axis shows the percentage of continuous abstinence, illustrating higher abstinence rates for CHANTIX compared to placebo throughout the study period.*

FDA Label Image

Logo (Chantix 05)

FDA Label Image

Logo (Chantix 06)

FDA Label Image

Principal Display Panel (0.5 / 1 mg Tablet Starting Pack Carton)

Packaging label for CHANTIX (varenicline) tablets, Starting Month Box containing 0.5 mg and 1 mg strengths. The film-coated oral tablet box includes 1 Starting Week supply (0.5 mg x 11 tablets) and 3 Continuing Weeks supply (1 mg x 42 tablets). Distributed by Pfizer Labs, this box is intended for the first four weeks of treatment and advises to use the green blister card first. Storage instructions and dosage guidelines are printed on the label.*

FDA Label Image

Principal Display Panel (0.5 mg / 1 mg Tablet Starting Pack)

The image is a packaging label for CHANTIX (varenicline) tablets Starting Pack by Pfizer Laboratories. It indicates a starting week blister card of 0.5 mg tablets (11 count) and three continuing weeks of 1 mg tablets (42 count). The label includes detailed blister pack layouts for daily morning and evening doses, storage instructions, lot and expiration fields, and a barcode.*

FDA Label Image

Principal Display Panel (0.5 mg Tablet Bottle Label)

Label for Chantix (varenicline) tablets 0.5 mg, film coated oral tablets, distributed by Pfizer Laboratories. The label includes storage instructions, dosage information, quantity of 56 tablets, and identifies the product as prescription only. The label also displays the NDC code and barcode.*

FDA Label Image

Principal Display Panel (1 mg Tablet Bottle Label)

Label for Chantix (varenicline) tablets by Pfizer Laboratories Division, Pfizer Inc. This label shows the 1 mg strength, film-coated oral tablets with 56 tablets per container. It includes storage instructions, manufacturer details, lot, expiration, and serial number fields, specifying prescription use only.*

FDA Label Image

Principal Display Panel (1 mg x 56 Tablet Continuing Pack)

CHANTIX (varenicline) continuing pack film-coated oral tablets containing 1 mg strength with 56 tablets, organized in blister packaging labeled by day and morning/evening dosage. The label shows dosing instructions for continuing weeks 3 and 4. Distributed by Pfizer Laboratories Division Pfizer Inc. Storage and dosage information included on the packaging.*

FDA Label Image

Principal Display Panel (1 mg x 56 Tablet Continuing Month Box)

CHANTIX (varenicline) tablets continuing month box packaging label displays the 1 mg strength for 4 continuing weeks, containing 56 film-coated tablets. The label shows Pfizer Labs as the distributor, indicates the product is made in Ireland, and includes storage instructions and dosage directions. The design features blue and white colors with the NDC 0069-0469-03 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.